SRNE Sorrento Therapeutics, Inc.

$0.00

Sorrento Therapeutics, Inc. (SRNE) SEC Filings

Everything SRNE has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

8 filings
Date Form Filing
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.